'Unaudited (standalone & consolidated) financial results for the quarter and half year ended on 30th…
As filed · Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Unaudited (standalone & consolidated) financial results for the quarter and half year ended on 30th September, 2026'.
What happened
FactUnaudited (standalone & consolidated) financial results for the quarter and half year ended on 30th September, 2026'. Reports thereon, as received from the Statutory Auditors, Walker Chandiok & Co. LLP. forthcoming quarter, as hundred per cent (100%) proceeds of the Initial Public Offer.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedSo, as we said, this will remain in teens, so largely 15-, 17-odd percent is what we expect.
Once we start doing it from the Zambian plant only, there might be some efficiencies in logistics, procurement, and cost reductions, so that might give us a couple of percent points better EBITDA.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- FY '26, if I say, we'll still be in losses, but the losses will be significantly curtailed down. (management committed by FY26)
- Last year, we did over INR40 crores of EBITDA losses, which we think this year will be in the range somewhere (management committed by FY25)
Evidence
- Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · FY26
- Latest statement · FY26
- Earlier statement · FY25
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%